Yicheng Yang

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

A carrier-free nanomedicine targeting vascular remodeling and oxidative stress for enhanced pulmonary arterial hypertension therapy.

A carrier-free nanomedicine targeting vascular remodeling and oxidative stress for enhanced pulmonary arterial hypertension therapy.

Journal: Journal of colloid and interface science

Published: October 15, 2025

Clinical Features and Survival in Fibrosing Mediastinitis: A Multicenter Cohort Study.

Clinical Features and Survival in Fibrosing Mediastinitis: A Multicenter Cohort Study.

Journal: Respiration; international review of thoracic diseases

Published: August 28, 2025

Ferroptosis promotes aortic stenosis through 5-lipoxygenase.

Ferroptosis promotes aortic stenosis through 5-lipoxygenase.

Journal: European heart journal

Published: July 08, 2025

Long-term outcomes and prognostic predictors in patients with fibrosing mediastinitis associated pulmonary hypertension: a multicenter cohort study.

Long-term outcomes and prognostic predictors in patients with fibrosing mediastinitis associated pulmonary hypertension: a multicenter cohort study.

Journal: Orphanet journal of rare diseases

Published: June 24, 2025

Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy.

Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy.

Journal: BMC medicine

Published: October 25, 2024

Trends and projections of heart failure among adolescents and young adults: an in-depth analysis for the Global Burden of Disease Study 2021.

Trends and projections of heart failure among adolescents and young adults: an in-depth analysis for the Global Burden of Disease Study 2021.

Journal: European heart journal. Quality of care & clinical outcomes

Published: October 03, 2024

The Challenge in Burden of Pulmonary Arterial Hypertension: A Perspective From the Global Burden of Disease Study.

The Challenge in Burden of Pulmonary Arterial Hypertension: A Perspective From the Global Burden of Disease Study.

Journal: MedComm

Published: September 02, 2024

Global research trends on chronic thromboembolic pulmonary hypertension: a bibliometric analysis (January 2000-January 2024).

Global research trends on chronic thromboembolic pulmonary hypertension: a bibliometric analysis (January 2000-January 2024).

Journal: Journal of thoracic disease

Published: June 12, 2024

Suppression of RCAN1 alleviated lipid accumulation and mitochondrial fission in diabetic cardiomyopathy.

Suppression of RCAN1 alleviated lipid accumulation and mitochondrial fission in diabetic cardiomyopathy.

Journal: Metabolism: clinical and experimental

Published: March 27, 2024

Cardiovascular disease therapeutics via engineered oral microbiota: Applications and perspective.

Cardiovascular disease therapeutics via engineered oral microbiota: Applications and perspective.

Journal: iMeta

Published: March 12, 2024

The significance of dynamic monitoring plasma TMAO level in pulmonary arterial hypertension - a cohort study.

The significance of dynamic monitoring plasma TMAO level in pulmonary arterial hypertension - a cohort study.

Journal: Therapeutic advances in respiratory disease

Published: January 11, 2024

Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy.

Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy.

Journal: BMC medicine

Published: September 20, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026